Illumina traded at $215.74 this Tuesday February 7th, increasing $7.04 or 3.37 percent since the previous trading session. Looking back, over the last four weeks, Illumina gained 4.07 percent. Over the last 12 months, its price fell by 39.19 percent. Looking ahead, we forecast Illumina to be priced at 207.23 by the end of this quarter and at 187.50 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
215.74
Daily Change
3.37%
Yearly
-39.19%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 154.51 2.27 1.49% 9.73%
Bio-Rad Laboratories 476.94 7.25 1.54% -22.78%
Bruker 72.20 0.70 0.98% 4.44%
Boston Scientific 48.09 0.43 0.90% 8.90%
Charles River Laboratories 252.64 5.73 2.32% -25.04%
Catalent 71.58 4.58 6.84% -29.25%
Quest Diagnostics 145.92 0.53 0.36% 8.47%
Danaher 266.00 2.25 0.85% -8.91%
Edwards Lifesciences 80.04 0.95 1.20% -28.16%
Exact Sciences 68.57 1.43 2.13% -12.93%
Standard Biotools Inc 2.05 0.03 1.49% -40.58%
Hologic 86.16 1.82 2.16% 16.37%
Illumina 215.74 7.04 3.37% -39.19%
IQVIA Holdings Inc 235.84 3.53 1.52% -4.66%
Intuitive Surgical 253.06 4.08 1.64% -13.39%
Laboratory Of America 247.24 2.74 1.12% -11.13%
Mettler Toledo International 1,557.94 1.96 0.13% 3.81%
Myriad Genetics 19.59 0.58 3.05% -24.77%
NanoString Technologies 12.18 0.09 0.74% -67.02%
OraSure Technologies 5.63 0.09 1.62% -39.33%
Pacific Biosciences Of California 11.25 -0.08 -0.71% 2.37%
PerkinElmer 139.50 1.60 1.16% -24.49%
Quidel 89.99 0.74 0.83% -5.29%
Repligen 193.85 1.83 0.95% 1.05%
Roche Holding 284.90 1.00 0.35% -17.64%
Bio Techne 78.44 2.87 3.80% -24.09%
Thermo Fisher Scientific 583.15 6.98 1.21% -1.14%
Waters 343.63 6.59 1.96% 4.47%
Dentsply International 38.64 0.55 1.44% -27.09%

Indexes Price Day Year
USND 12114 226.34 1.90% -14.66%
USNDX 12732 263.76 2.12% -15.44%
US500 4162 52.92 1.29% -9.27%

Illumina
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.